Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-28

FDA Approved: AMBRISENTAN — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved the original ANDA for ambrisentan from Sun Pharmaceutical Industries, Inc., granting a generic version of the drug. Ambrisentan is used to treat pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)